UNSPSC 85445503: The diagnosis of methylxanthines

In this classification, this covers the group of activities that yields a diagnosis of methylxanthines, not elsewhere classified. Methylxanthines, not elsewhere classified is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y50.2.

UNSPSC 85445503 The diagnosis of methylxanthines is a Commodity code that does not align with the recent state and local contract opportunities posted under it. The three most recent opportunities — a diagnostic imaging PACS system from San Mateo Medical Center, an ultrasound equipment procurement from Collier County, Florida, and blood draw phlebotomy services from Albuquerque Police Department — involve medical imaging systems, diagnostic ultrasound hardware, and phlebotomy services respectively. None of these solicitations involve the diagnosis of methylxanthines (a pharmaceutical and toxicology testing category). The code shows minimal relevant recent activity; the opportunities tagged to it appear to reflect data-classification errors rather than genuine procurement aligned with the code's nominal scope.

State and local buyers using this code (or misusing it in their tagging) span county health systems, municipal police departments, and county procurement divisions across California, Florida, and New Mexico. Without authentic methylxanthine-diagnosis opportunities in the recent record, a business development professional should treat this code as inactive for practical pursuit and flag the tagging inconsistency in portfolio management systems. If methylxanthine diagnostic services are genuinely needed by state or local health systems or public safety agencies, those requirements are not surfacing under this UNSPSC code in current procurement channels.